News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Resmetirom proves efficacy in NASH patients with or without MetALD
20 Jun 2024
byStephen Padilla
Patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and fibrosis treated with resmetirom achieve NASH resolution with no fibrosis worsening (NR) or ≥1-stage fibrosis improvement with no worsening of the NAS score (FI), according to the results of the ongoing MAESTRO-NASH study.
20 Jun 2024

Seladelpar extends benefit to PBC patients with compensated liver cirrhosis
20 Jun 2024
byAudrey Abella
An interim analysis of the open-label phase III ASSURE study finds benefit in seladelpar, a novel delpar (a potent and selective PPAR*-delta agonist), for individuals with primary biliary cholangitis (PBC) and compensated liver cirrhosis.
20 Jun 2024

Statin use may reduce mortality in early breast cancer
19 Jun 2024
byStephen Padilla
The addition of statins to standard adjuvant breast cancer treatment, particularly in combination with chemotherapy, appears to improve patient survival, suggests a study presented at ESMO Breast Cancer 2024.
19 Jun 2024





